Article 05 Jun 2024 Amgen Files BPCIA Lawsuit Against Celltrion's Proposed Prolia® / Xgeva® (Denosumab) Biosimilar CT-P41 United States Healthcare
Article 05 Jun 2024 U.S. Patent And Trademark Office Rejects 'Contingent' Terminal Disclaimer United States IP
Article 04 Jun 2024 National Telecommunications And Information Administration Seeks Comments Regarding The Advancement Of 6G Technology United States Media & IT
Article 04 Jun 2024 Colorado's Landmark AI Law: Essential Insights For Businesses United States Technology
Article 31 May 2024 Fresenius Kabi Announces FDA Acceptance Of ABLA For Prolia® / Xgeva® (Denosumab) Biosimilar Candidate FKS518 United States IP
Article 29 May 2024 Regeneron Files Second BPCIA Complaint Against Celltrion's Proposed EYLEA® Biosimilar CT-P42 United States IP
Article 29 May 2024 Fairfax County To Consider Zoning Changes Related To Future Data Center Development United States Real Estate
Article 29 May 2024 Summary Of LDT Rule: An In-Depth Look At The Final Rule Regarding Laboratory-Developed Tests United States Healthcare
Article 29 May 2024 New Federal Acquisition Regulatory Council Pay Equity Rule Puts Contractors Between A Rock And A Hard Place United States Government